Sort   by:  
 Page size 
UnknownPopulation Pharmacokinetics of Ponatinib in Healthy Adult Volunteers and Patients With Hematologic Malignancies and Model-Informed Dose Selection for Pediatric Development.
Not available
S-EPMC9300170 | biostudies-literature
UnknownPopulation Pharmacokinetic Analysis of Ixazomib, an Oral Proteasome Inhibitor, Including Data from the Phase III TOURMALINE-MM1 Study to Inform Labelling.
Not available
S-EPMC5648746 | biostudies-literature
UnknownPopulation Pharmacokinetic Analysis of Bortezomib in Pediatric Leukemia Patients: Model-Based Support for Body Surface Area-Based Dosing Over the 2- to 16-Year Age Range.
Not available
S-EPMC5561493 | biostudies-literature
UnknownIntra- and inter-molecular effects of a conserved arginine residue of neuronal and inducible nitric oxide synthases on FMN and calmodulin binding.
Not available
S-EPMC3779284 | biostudies-literature
UnknownPharmacokinetic and pharmacodynamic study of two doses of bortezomib in patients with relapsed multiple myeloma.
Not available
S-EPMC3951913 | biostudies-literature
UnknownPharmacokinetics and pharmacodynamics of liposomal mifamurtide in adult volunteers with mild or moderate renal impairment.
Not available
S-EPMC4093924 | biostudies-literature
UnknownImplementation Intention and Reminder Effects on Behavior Change in a Mobile Health System: A Predictive Cognitive Model.
Not available
S-EPMC5730820 | biostudies-literature
UnknownMechanism of Substrate Translocation in an Alternating Access Transporter.
Not available
S-EPMC5557413 | biostudies-literature
UnknownSialoglycans modulate Siglec-5-TLR4 interactions in osteoarthritis.
Not available
S-EPMC12677102 | biostudies-literature
UnknownMifamurtide in metastatic and recurrent osteosarcoma: a patient access study with pharmacokinetic, pharmacodynamic, and safety assessments.
Not available
S-EPMC4533988 | biostudies-literature
Sort   by:  
 Page size